Atlas Trials

Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction

Clinical trial NCT04210180 · COMPLETED

Trial details

NCT number
NCT04210180
Sponsor
Rose Research Center, LLC
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Smoking CessationHarm Reduction
Start date
2019-11-19
Primary completion
2020-10-14
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.